Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

Cellebrite DI (CLBT) EBIT Margin (2020 - 2025)

Historic EBIT Margin for Cellebrite DI (CLBT) over the last 6 years, with Q3 2025 value amounting to 15.07%.

  • Cellebrite DI's EBIT Margin fell 31300.0% to 15.07% in Q3 2025 from the same period last year, while for Sep 2025 it was 13.47%, marking a year-over-year decrease of 11200.0%. This contributed to the annual value of 14.18% for FY2024, which is 39600.0% up from last year.
  • As of Q3 2025, Cellebrite DI's EBIT Margin stood at 15.07%, which was down 31300.0% from 12.73% recorded in Q2 2025.
  • Over the past 5 years, Cellebrite DI's EBIT Margin peaked at 18.2% during Q3 2024, and registered a low of 8.95% during Q2 2022.
  • Its 5-year average for EBIT Margin is 9.08%, with a median of 11.41% in 2025.
  • As far as peak fluctuations go, Cellebrite DI's EBIT Margin tumbled by -228400bps in 2022, and later surged by 175300bps in 2023.
  • Cellebrite DI's EBIT Margin (Quarter) stood at 6.34% in 2021, then soared by 106bps to 13.07% in 2022, then rose by 23bps to 16.13% in 2023, then dropped by -11bps to 14.42% in 2024, then rose by 4bps to 15.07% in 2025.
  • Its last three reported values are 15.07% in Q3 2025, 12.73% for Q2 2025, and 11.41% during Q1 2025.